- Home
- XLO vs RFIL Comparison
XLO vs RFIL Comparison
Compare XLO & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- RFIL
- Stock Information
- Founded
- XLO 2016
- RFIL 1979
- Country
- XLO United States
- RFIL United States
- Employees
- XLO N/A
- RFIL N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- RFIL Electrical Products
- Sector
- XLO Health Care
- RFIL Technology
- Exchange
- XLO Nasdaq
- RFIL Nasdaq
- Market Cap
- XLO 37.9M
- RFIL 39.9M
- IPO Year
- XLO 2021
- RFIL N/A
- Fundamental
- Price
- XLO $0.75
- RFIL $3.82
- Analyst Decision
- XLO Buy
- RFIL Strong Buy
- Analyst Count
- XLO 1
- RFIL 1
- Target Price
- XLO $4.00
- RFIL $4.50
- AVG Volume (30 Days)
- XLO 233.4K
- RFIL 38.1K
- Earning Date
- XLO 05-13-2025
- RFIL 06-12-2025
- Dividend Yield
- XLO N/A
- RFIL N/A
- EPS Growth
- XLO N/A
- RFIL N/A
- EPS
- XLO N/A
- RFIL N/A
- Revenue
- XLO $6,344,000.00
- RFIL $70,599,000.00
- Revenue This Year
- XLO $668.96
- RFIL $16.16
- Revenue Next Year
- XLO $14.49
- RFIL $5.75
- P/E Ratio
- XLO N/A
- RFIL N/A
- Revenue Growth
- XLO N/A
- RFIL 4.93
- 52 Week Low
- XLO $0.62
- RFIL $2.86
- 52 Week High
- XLO $1.70
- RFIL $5.77
- Technical
- Relative Strength Index (RSI)
- XLO 50.44
- RFIL 40.43
- Support Level
- XLO $0.63
- RFIL $3.76
- Resistance Level
- XLO $0.80
- RFIL $4.17
- Average True Range (ATR)
- XLO 0.06
- RFIL 0.30
- MACD
- XLO 0.01
- RFIL -0.05
- Stochastic Oscillator
- XLO 72.93
- RFIL 28.48
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.